How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Surgical Preoperative Planning Software Market
- By Surgical Specialty: Orthopedic Surgery, Neurosurgery, Cardiovascular Surgery, ENT Surgery, Plastic and Reconstructive Surgery
- By Software Deployment Mode: On-Premise Software, Cloud-Based Software, Hybrid Deployment
- By End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Research and Academic Institutions
- By Functionality: 3D Visualization and Modeling, Surgical Simulation and Training, Preoperative Risk Assessment, Image Segmentation and Analysis, Surgical Workflow Management
- By Imaging Modality Integration: CT Scan Integration, MRI Integration, Ultrasound Integration, X-Ray Integration, PET Scan Integration
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Orthopedic Surgery leads By Surgical Specialty at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 298 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.181 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.189 →
Full report · locked preview
Everything inside the Surgical Preoperative Planning Software Market report
A complete, evidence-based study - 12 chapters and 125 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Surgical Specialty 5
Software Deployment Mode 3
End User 4
Functionality 5
Imaging Modality Integration 5
Companies profiled
Medtronic
Stryker Corporation
Zimmer Biomet Holdings Inc.
Materialise NV
Brainlab AG
3D Systems Corporation
DePuy Synthes (Johnson & Johnson)
Sectra AB
SurgiCase (SurgiCase Software)
Dextroscope (Volume Interactions Pte Ltd)
Anatomage Inc.
Stryker's Mako Surgical Corp.
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Medtronic
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Stryker Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Zimmer Biomet Holdings Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Materialise NV
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Brainlab AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →3D Systems Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →DePuy Synthes (Johnson & Johnson)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Sectra AB
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →SurgiCase (SurgiCase Software)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Dextroscope (Volume Interactions Pte Ltd)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Anatomage Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Stryker's Mako Surgical Corp.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →GE Healthcare
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Siemens Healthineers
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Philips Healthcare
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$1,621M by 2033 · 4.5% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Orthopedic Surgery39.1
- Neurosurgery7.2
- Cardiovascular Surgery12.6
- ENT Surgery20.6
- Plastic and Reconstructive Surgery20.6
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$377.1M → $592.4M · 5.8%
Europe$262.8M → $397.1M · 5.3%
Asia Pacific$240.0M → $336.5M · 4.3%
Latin America$148.6M → $190.0M · 3.1%
Middle East and Africa$114.3M → $150.4M · 3.5%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →4.422026
4.432027
4.442028
4.452029
4.462030
4.482031
4.482032
4.502033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Medtronic10.5
- Stryker Corporation19.8
- Zimmer Biomet Holdings Inc.12.1
- Materialise NV12.7
- Brainlab AG5.8
- 3D Systems Corporation11.1
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Surgical Specialty26.6%
Software Deployment Mode20.8%
End User18.5%
Functionality20.6%
Imaging Modality Integration13.5%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America35.6
- Europe23.8
- Asia Pacific20.2
- Latin America11.4
- Middle East and Africa9.0
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Medtronic | 76 | 74 | 95 | 94 | 86 | 81 | 84 |
| Stryker Corporation | 83 | 84 | 73 | 71 | 69 | 93 | 79 |
| Zimmer Biomet Holdings Inc. | 86 | 86 | 82 | 75 | 69 | 66 | 77 |
| Materialise NV | 82 | 69 | 68 | 60 | 81 | 71 | 72 |
| Brainlab AG | 56 | 54 | 52 | 74 | 67 | 69 | 62 |
| 3D Systems Corporation | 59 | 56 | 47 | 69 | 66 | 63 | 60 |
| DePuy Synthes (Johnson & Johnson) | 53 | 50 | 61 | 47 | 43 | 65 | 53 |
| Sectra AB | 54 | 52 | 49 | 41 | 43 | 59 | 50 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Medtronic
- Stryker Corporation
- Zimmer Biomet Holdings Inc.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Medtronic | ◐ | ◐ | ◐ | ✓ | ✓ | ✓ |
| Stryker Corporation | ◐ | ◐ | ✓ | − | ◐ | ✓ |
| Zimmer Biomet Holdings Inc. | ✓ | ✓ | ✓ | ✓ | ◐ | − |
| Materialise NV | ✓ | ◐ | − | − | ◐ | ✓ |
| Brainlab AG | − | ◐ | ◐ | ✓ | ◐ | ◐ |
| 3D Systems Corporation | ◐ | ◐ | − | ◐ | − | − |
| DePuy Synthes (Johnson & Johnson) | − | − | − | − | − | ◐ |
| Sectra AB | − | − | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Medtronic84
2Stryker Corporation79
3Zimmer Biomet Holdings Inc.77
4Materialise NV72
5Brainlab AG62
63D Systems Corporation60
7DePuy Synthes (Johnson & Johnson)53
8Sectra AB50
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
MedtronicStryker Corporation
Challenger2
Strong scale, closing on the leaders.
Zimmer Biomet Holdings Inc.Materialise NV
Contender2
Focused players with pockets of strength.
Brainlab AG3D Systems Corporation
Niche2
Specialists in a single segment or region.
DePuy Synthes (Johnson & Johnson)Sectra AB
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Surgical Specialty in North America, then scale across Surgical Preoperative Planning Software Market — a $79M beachhead inside a $1.17B market.
Beachhead (SOM)$79Mobtainable near-term
Serviceable (SAM)$425Mreachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Orthopedic Surgery
Best fit — highest urgency & budget in Surgical Specialty.
Economic buyer76 fit
Neurosurgery
Strong fit — clear ROI and a fast path to value.
End user67 fit
Cardiovascular Surgery
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Surgical Specialty in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Software Deployment Mode & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel29%
Digital / self-serve20%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Surgical Specialty leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Surgical Preoperative Planning Software Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified43%
Sales qualified23%
Evaluation15%
Closed-won8%
$20.7KCAC
$115KLTV
5.5:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Surgical Preoperative Planning Software Market is a high-growth opportunity — $4.32B by 2033, compounding at 10.5%.
TAM · 2025$1.94Btoday
TAM · 2033$4.32Bforecast
CAGR10.5%2027–2033
Cumulative$27.0Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$4.32BTotal addressable market
SAM$1.58BServiceable available market
SOM$295MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →10.5% CAGR
Demand compounds through 2033, outpacing GDP across Surgical Specialty.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Surgical Specialty moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$4.32BLarge & growingTAM by 2033 at 10.5% CAGR
$1.58BServiceable nowreachable with today’s model
$295MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.37BBear6.8% CAGR
$4.32BBase10.5% CAGR
$5.53BBull13.9% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Software Deployment Mode optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Surgical Preoperative Planning Software Market — a $2.54B market by 2033. Plan: grow share from 9.5% to 18.2%.
Market size · 2033$2.54Btotal addressable
Market CAGR8.7%2027–2033
Target share18.2%from 9.5% today
Revenue ambition$462Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.5% | 18.2% | On track |
| Revenue | $224M | $462M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Ahead |
| Gross margin | 34.8% | 45.4% | At risk |
| Customer retention | 86.5% | 96.6% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Surgical Specialty
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Software Deployment Mode capability
A defensible second engine — invest in Software Deployment Mode to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Surgical Specialty share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Software Deployment Mode
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $53M capacity & capability investment
- Greenlight bolt-on M&A in Software Deployment Mode
- Authorise North America expansion plan
- Fund R&D program for Surgical Specialty leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossOn track
- Input-cost & supply riskBehind
- Regulatory / policy changeAhead
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Surgical Preoperative Planning Software Market conversation — a $3.37B market you can size, segment and defend in minutes.
Market size · 2033$3.37Btotal opportunity
Growth4.4%CAGR to 2033
Addressable buyers1,584+accounts in scope
Typical ROI6×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Surgical Specialty
Goal Grow share in Surgical Specialty
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6×return on cost, year one
< 3 mopayback period
$59K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
MedtronicStryker CorporationZimmer Biomet Holdings Inc.Materialise NVBrainlab AG3D Systems CorporationDePuy Synthes (Johnson & Johnson)Sectra AB+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Surgical Preoperative Planning Software Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Surgical Preoperative Planning Software Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →3D Printing in Pharmaceutical Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View report3D Printing in Orthopedics Market
Market size, share, segmentation and regional forecast.
$2.0B market · 2025 base year
View report3D Printing in Medical Devices Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View report3D Printing for Surgical Procedures Market
3D Printing for Surgical Procedures Market is valued at USD 1.75 Billion in 2025 and is expecte…
$1.8B market · 2025 base year
View report3D Printing for Medical Market
Market size, share, segmentation and regional forecast.
$2.0B market · 2025 base year
View report3D Printing for Medical Device Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View report3D Printing for Implantology Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportFuneral Services Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View report3D Printing for Dental Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View report3D Printing for Audiology Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View report3D Printing Drug Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View report3D Printing Drug Formulation and Administration Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.